1-1 of 1
Inge A Ivens, PhD., D.A.B.T.
Close
Sort by
Journal Articles

BAY 94–9027, a PEGylated Recombinant Human FVIII, Shows Less Immunogenicity Compared to Un-PEGylated Recombinant FVIII

Inge A Ivens, PhD., D.A.B.T., Ruprecht Zierz, PhD, Jesper Haaning, PhD, Thomas McDonald, MPH, PhD
Journal: Blood
Blood (2010) 116 (21): 2214.
https://doi.org/10.1182/blood.V116.21.2214.2214
Published: 2010